ArticleCureus2025
Sleep Disorders and Optic Neuritis Risk in Multiple Sclerosis: A Retrospective Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This retrospective cohort study investigates the relationship between sleep disorders and the risk of developing optic neuritis in patients with multiple sclerosis (MS). Utilizing data from the TriNetX Global Collaborative Network, we analyzed two matched cohorts as follows: MS patients with documented sleep disorders (n = 48,995) and those without (n = 48,995). Propensity score matching ensured balance in baseline characteristics, minimizing confounding factors. Our findings revealed a significantly increased incidence of optic neuritis among MS patients with sleep disorders, with a 3.0% absolute risk increase compared to the control cohort. This association corresponded to an odds ratio of 1.532, indicating a substantial elevation in risk. Kaplan-Meier survival analysis further supported this link, demonstrating a 31.5% higher hazard of developing optic neuritis over time in patients with sleep disorders. These results emphasize the importance of integrating sleep health evaluations into MS management protocols. Proactively addressing sleep disorders may reduce the occurrence of optic neuritis, potentially improving the quality of life and long-term outcomes for MS patients. Future studies should explore the impact of specific sleep disorder subtypes and investigate the underlying biological mechanisms to better understand and mitigate this risk. This work underscores the broader implications of sleep health in chronic disease management and the potential for targeted interventions to alleviate disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.